HomeUncategorizedUS Supreme Court rejects TCS challenge to $168m award in trade secret...

US Supreme Court rejects TCS challenge to $168m award in trade secret case

Published on

spot_img

Bringing a final resolution to a multi-year corporate espionage battle, the U.S. Supreme Court has rejected an appeal from India’s largest IT services exporter, Tata Consultancy Services (TCS).

By declining to review the case, the apex court has let stand a lower court’s $168 million damages award in favor of Virginia-based DXC Technology, which accused TCS of willfully stealing proprietary trade secrets to build a competing software platform.

Financial Impact: TCS Braces for a $220 Million Total Hit

Following the Supreme Court’s order, TCS issued a formal regulatory filing acknowledging the outcome and clarifying the final financial hit to its balance sheet:

  • The Core Award: The $168 million judgment is split into $56 million in compensatory damages and $112 million in punitive damages.
  • Total Exposure: When accounting for accrued interest, back-dated inflation metrics, and legal fees over years of litigation, TCS’s total financial exposure has swelled to $220 million (~₹2,080 crore).
  • The New Hit: Having already provisioned $150 million in its accounts for this legal dispute, TCS confirmed it will book an additional $70 million one-time exceptional charge during the first quarter of FY27 to completely cover the shortfall.

Anatomy of the Case: The Transamerica Talent Drain

The roots of the legal battle date back to a 2019 lawsuit filed in a Dallas federal court by DXC Technology’s predecessor, Computer Sciences Corporation (CSC).

CSC had historically developed complex, proprietary software systems to manage life insurance and annuities policies, licensing the software to financial giant Transamerica in the 1990s. The core operational timeline outlines a deliberate bypass of intellectual property:

Year / StageCase Progression & Core Operational Motions
The 2014 PivotTCS absorbs a massive administrative contract from Transamerica, managing its core back-office infrastructure.
The Employee MigrationTCS hires roughly 2,200 Transamerica workers who held deep, day-to-day administrative access to CSC’s underlying source code.
The IP MisappropriationDXC proves that TCS utilized these workers’ access credentials to scrape internal data and map out the software’s functional architecture.
The Competitor ProductTCS uses the scraped insights to rapidly accelerate and market its own competing, proprietary life insurance platform.

TCS fiercely contested the claims throughout the multi-stage litigation, arguing that the information accessed by its workers was not legally classified as a “secret,” and that no direct losses were suffered by DXC.

In its petition to the Supreme Court, TCS’s legal team attempted to challenge the fundamental framework of how American trade secret damages are calculated. TCS argued that under U.S. federal laws, a plaintiff shouldn’t be awarded “unjust enrichment” damages (the money TCS saved by cutting R&D corners via stolen code) unless the plaintiff could first mathematically prove it suffered equivalent “actual economic loss.”

The high court was entirely unpersuaded by the distinction. Under current U.S. trade secret jurisprudence, courts consistently maintain that companies cannot use competitor IP as a free shortcut to build rival software, regardless of whether the original creator lost immediate customers during the breach.

The closure of the case marks the second major high-value trade secrets blow TCS has absorbed in the U.S. court system, arriving on the heels of a separate, finalized $140 million punitive judgment won by electronic health records provider Epic Systems.

Latest articles

Nvidia to raise $25B, first bond sale since 2021

Joining the massive, multi-billion-dollar corporate fundraising wave sweeping through the artificial intelligence sector, Nvidia...

Indian Govt tightens cough syrup sale rules

nion Health Ministry has officially ended the over-the-counter (OTC) sale of all syrup-based medicines,...

Sarvam AI raises $234m at $1.5B valuation

Bengaluru-based Sarvam AI has officially vaulted into the unicorn club. The full-stack generative AI...

Axis Life Insurance posts 99.8% death claim payout

Following its official rebranding and structural consolidation under Axis Bank, Axis Max Life Insurance...

More like this

Nvidia to raise $25B, first bond sale since 2021

Joining the massive, multi-billion-dollar corporate fundraising wave sweeping through the artificial intelligence sector, Nvidia...

Indian Govt tightens cough syrup sale rules

nion Health Ministry has officially ended the over-the-counter (OTC) sale of all syrup-based medicines,...

Sarvam AI raises $234m at $1.5B valuation

Bengaluru-based Sarvam AI has officially vaulted into the unicorn club. The full-stack generative AI...